Home
About Us
The Chru Team
Departments
Clinical
Counselling
Data Management
Finance and Administration
Governance
Pharmacy
Quality Assurance
Regulatory
Research Sites
Research
Networks and Funding
Collaborations and sponsors
Clinical Trials
HIV/Aids
TB
HIV-associated cancers
COVID-19
Other studies
Recent Research Highlights
Resources
Publications
Recent Publications
2018
2017
2016
2015
2014
2013
2012
Before 2012
International conferences
Participate
Your Protection
Community Advisory Board
About
Role
Contact
Activities
Resources
Q&A
News
Media Releases
Latest News
Media Coverage
Contact
info@chru.co.za
+27 (11) 276 8800
Support
Home
About Us
The Chru Team
Departments
Clinical
Counselling
Data Management
Finance and Administration
Governance
Pharmacy
Quality Assurance
Regulatory
Research Sites
Research
Networks and Funding
Collaborations and sponsors
Clinical Trials
HIV/Aids
TB
HIV-associated cancers
COVID-19
Other studies
Recent Research Highlights
Resources
Publications
Recent Publications
2018
2017
2016
2015
2014
2013
2012
Before 2012
International conferences
Participate
Your Protection
Community Advisory Board
About
Role
Contact
Activities
Resources
Q&A
News
Media Releases
Latest News
Media Coverage
Contact
August 11, 2021
Day
11
Aug
Highly drug-resistant TB treatment trial shows reduced side effects
August 11, 2021
By
admin
CHRU’S LATEST NEWS
Highly drug-resistant TB treatment trial shows reduced side effects
Read More
Recent Posts
SA research leads to new WHO guidelines for improved TB treatment
CHRU supports global effort to promote the use of vaccines
I bear testimony to the fact that even MDR-TB can be cured
Community-driven TB month campaign
Ongoing advances in HIV treatment
Archives
May 2022
April 2022
November 2021
August 2021
May 2021
March 2021
February 2021
December 2020
November 2020
March 2020
December 2019
October 2019
September 2019
Categories
CHRU’S LATEST NEWS
Media Releases
Uncategorized
Meta
Log in
Entries feed
Comments feed
WordPress.org
